Lonza has made an approved offer of $1.4bn for Arch Chemicals. The deal will give Lonza a word-leading presence in microbial control and will reduce the companies dependence on contract manufacturing.
NYT Deal Book
Monday 11 July 2011
Lonza to buy Arch
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment